| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |